ADVERTISEMENT
Search

 

Press Releases

 

2

Jun

2022

APhA Changes Executive Leadership

Ilisa Bernstein appointed Interim CEO

The Board of Trustees of the American Pharmacists Association announced today that Ilisa Bernstein, PharmD, JD, FAPhA, has been named Interim CEO, effective immediately. Bernstein’s appointment follows the departure of Scott Knoer, PharmD, MS, as Executive Vice-President and CEO.

Comments (0)
Number of views (17665)
Article rating: No rating

26

May

2022

APhA statement on Texas Mass Shooting

WASHINGTON, DC—The American Pharmacists Association (APhA) is deeply saddened by the horrific mass shooting in Uvalde, Texas, elementary school in which a gunman took the lives of at least 19 young children and two dedicated teachers.

Comments (0)
Number of views (2904)
Article rating: No rating

16

Feb

2022

APhA congratulates Robert Califf, MD, on confirmation as FDA Commissioner

Author: Renee Kalu

WASHINGTON, D.C.—The American Pharmacists Association (APhA) issued the following statement to congratulate Robert Califf, MD, on his confirmation to serve once again as commissioner of FDA. APhA looks forward to working with both Califf and the FDA to ensure the safety, efficacy, and security of medications for our nation’s pharmacy patients.

Comments (0)
Number of views (3026)
Article rating: No rating

29

Mar

2021

American Pharmacists Association Collaborates with CDC to Build the Public's Confidence in COVID-19 Vaccines

WASHINGTON, DC – The American Pharmacists Association (APhA) announced today that it has entered into a collaborative agreement with the Centers for Disease Control and Prevention (CDC) to support the CDC’s efforts to build the American public’s confidence in the COVID-19 vaccines. 

Comments (0)
Number of views (4989)
Article rating: No rating
RSS
First91011121314151618
Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT